Stock Research for BIOL

BIOL
Current Price

$0.4200


Latest Update: 2018-02-23 16:00:00

High
$ 0.4200
Low
$ 0.4200
Close
$ 0.4200
Volume
628
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

BIOL Stock Chart & Research Data

The BIOL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIOL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BIOL Due diligence Resources & Stock Charts

The BIOL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BIOL Detailed Price Forecast - CNN Money CNN View BIOL Detailed Summary - Google Finance
Yahoo View BIOL Detailed Summary - Yahoo! Finance Zacks View BIOL Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View BIOL Trends & Analysis - Trade-Ideas Barrons View BIOL Major Holders - Barrons
NASDAQ View BIOL Call Transcripts - NASDAQ Seeking View BIOL Breaking News & Analysis - Seeking Alpha
Spotlight View BIOL Annual Report - CompanySpotlight.com OTC Report View BIOL OTC Short Report - OTCShortReport.com
TradeKing View BIOL Fundamentals - TradeKing Charts View BIOL SEC Filings - Bar Chart
WSJ View Historical Prices for BIOL - The WSJ Morningstar View Performance/Total Return for BIOL - Morningstar
MarketWatch View the Analyst Estimates for BIOL - MarketWatch CNBC View the Earnings History for BIOL - CNBC
StockMarketWatch View the BIOL Earnings - StockMarketWatch MacroAxis View BIOL Buy or Sell Recommendations - MacroAxis
Bullish View the BIOL Bullish Patterns - American Bulls Short Pains View BIOL Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View BIOL Stock Mentions - StockTwits PennyStocks View BIOL Stock Mentions - PennyStockTweets
Twitter View BIOL Stock Mentions - Twitter Invest Hub View BIOL Investment Forum News - Investor Hub
Yahoo View BIOL Stock Mentions - Yahoo! Message Board Seeking Alpha View BIOL Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for BIOL - SECform4.com Insider Cow View Insider Transactions for BIOL - Insider Cow
CNBC View BIOL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BIOL - OTC Markets
Yahoo View Insider Transactions for BIOL - Yahoo! Finance NASDAQ View Institutional Holdings for BIOL - NASDAQ


Stock Charts

FinViz View BIOL Stock Insight & Charts - FinViz.com StockCharts View BIOL Investment Charts - StockCharts.com
BarChart View BIOL Stock Overview & Charts - BarChart Trading View View BIOL User Generated Charts - Trading View


Latest Financial News for BIOL

BIOLASE Announces Initiatives to Increase Dental Laser Awareness and Education in Southern California
Posted on Thursday February 15, 2018

IRVINE, Calif., Feb. 15, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, announced today that it is bolstering its efforts in Southern California to significantly enhance the region's oral health and dental care by increasing awareness and education in laser dentistry. BIOLASE is adding local specialists to its staff to offer dentists more support in maximizing the use of their lasers.


Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement
Posted on Wednesday February 07, 2018

IRVINE, Calif. , Feb. 7, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the world's leading dental laser company, today announced that the Listing Qualifications Department of the Nasdaq Stock Market ...


BIOLASE Rejects Frivolous, Abusive Patent Litigation
Posted on Thursday January 25, 2018

IRVINE, Calif., Jan. 25, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the world's leading dental laser company, today released the following statement in response to the latest attempt by CAO Group, Inc. to use patent litigation to try to improve its competitive position in the marketplace. BIOLASE is well-known for its own innovations, and for respecting the valid intellectual property rights of others. It is not surprising that CAO has failed for years in its attempts to intimidate BIOLASE through abusive patent litigation.


CAO Group, Inc. Protects Its Diode Laser Patent Rights From Infringement By Biolase, Inc.
Posted on Wednesday January 24, 2018

SALT LAKE CITY , Jan. 24, 2018 /PRNewswire/ -- CAO Group, Inc. (CAO) has filed patent infringement lawsuits in the United States District Court for the State of Utah and in the United States District Court ...


BIOLASE Announces Initiatives to Increase Dental Laser Awareness and Education ...
PR Newswire (press release) - Feb 15, 2018
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners ...

BIOLASE's (BIOL) CEO Harold Flynn on Q3 2017 Results - Earnings Call Transcript
Seeking Alpha - Nov 2, 2017
Good afternoon, everyone, and welcome to the BIOLASE conference call to discuss the results for the company's third quarter and nine months ended September 30, 2017.
BIOLASE Reports 2017 Third Quarter and Nine-Month Results - Business Wire (press release)

BIOLASE Announces Commencement of Rights Offering
Business Wire (press release) - Nov 9, 2017
IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has commenced its previously announced rights offering to holders of shares of its common stock.

BIOLASE Announces Terms of Rights Offering
Business Wire (press release) - Nov 3, 2017
IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the terms of its previously announced rights offering to holders of shares of its common stock.

Enter a stock symbol to view the stock details.